Equity Overview
Price & Market Data
Price: $0.071
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $106,874
Volume: 0
Performance Metrics
1 Week: 18.33%
1 Month: -40.83%
3 Months: 17.16%
6 Months: -36.09%
1 Year: -52.67%
YTD: 17.16%
Details
Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022. The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada.